Status:

COMPLETED

Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Narcolepsy

Hypersomnia

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The project will improve scientific knowledge regarding a recent law applying potentially to every french driver. It will give for the first time an indication on the impact of alerting treatments on ...

Detailed Description

Excessive daytime sleepiness is responsible of 20% of traffic accidents and 2/3 of truck accidents on French Freeways. Since the publication of a new law (arrêté du 28 décembre 2005 du journal officie...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Patients:
  • Narcoleptic patients with or without cataplexy or hypersomniacs
  • aged from 18 to 65 years,
  • treated for attacks of cataplexy,
  • treated with a maximum dose of Modiodal: 400 mg per day (4 tablets of 100mg),
  • without any other disease which could be responsible of excessive daytime sleepiness,
  • having their driver's licence,
  • driving more than 5000 Km/year,
  • registered to French national health and pensions organization,
  • having regular timetables of life 7 days before beginning the study,
  • having given their written light agreement in order to participate in the study.
  • Inclusion Criteria for Healthy Volunteers:
  • without any sleep disorders,
  • having their driver's licence since at least 2 years,
  • driving more than 5000 Km/year,
  • registered to French national health and pensions organization,
  • having regular timetables of life 7 days before beginning the study,
  • having given their written light agreement in order to participate in the study.
  • Exclusion Criteria for Patients:
  • Night workers,
  • breast-feeding or pregnant women
  • Beck's scale score \< 8,
  • neurologic disease,
  • cardiovascular disorders including cardiac arrhythmia,
  • sleep disorders except narcolepsy and hypersomnia,
  • pulmonary disorders,
  • renal disorders,
  • endocrinal disorders,
  • having participated in a clinical study during the last 6 months,
  • unable to drive.
  • Exclusion Criteria for Healthy Volunteers:
  • Night workers,
  • neurologic disease,
  • cardiovascular disorders,
  • sleep disorders,
  • pulmonary disorders,
  • renal disorders,
  • endocrinal disorders,
  • having participated in a clinical study during the last 6 months,
  • unable to drive.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2012

    Estimated Enrollment :

    27 Patients enrolled

    Trial Details

    Trial ID

    NCT00916253

    Start Date

    March 1 2010

    End Date

    August 1 2012

    Last Update

    April 25 2013

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    GENNPHASS - CHU de Bordeaux

    Bordeaux, France, 33076

    2

    AP-HP - Hôpital de l'Hôtel-Dieu

    Paris, France, 75181